We investigated the chemotactic activity of interleukin (1L)-12 on human natural killer (NK) cells and other leukocyte subsets. It was found that IL-12 induced directional migration of highly enriched preparations of NK cells (>80% CD16+ and CD56+) and CD3-activated T cells (both of CD4 and CD8 subset), but not resting T cells and monocytes. On the contrary, purified polymorphonuclear cells (PMN) showed significant and reproducible chemotactic response to 11-12. The effects of IL-12 on leukocyte migration were observed in a narrow concentration range with a peak at approximately 7.5 ng/mL, and were abrogated by monoclonal antibody (MoAb) anti-IL-12 or after cytokine boiling. We also investi-
ATURAL KILLER (NK) cells comprise 5% to 10% of blood mononuclear cells and are characterized by the typical morphology of large granular lymphocytes (LGLs) and the CD3-CD16TD56' phenotype. NK cells are cytotoxic without prior sensitization for a wide range of target cells, including some microorganisms and virus-infected and transformed cells. In addition to cytotoxicity, NK cells secrete cytokines and have a central role in the regulation of the immune response and hematopoiesis.'" Most NK cells are found mainly in blood and spleen, but they are present also in the lung and intestinal mucosa, and accumulate in liver parenchyma on cytokine administration in mice. ' In certain pathologic conditions, NK cells accumulate at extrahematic sites following viral and bacterial infection^,^.^ and are found in the allograft infiltrate during the early phase of rejection?
The mechanisms underlying NK-cell recruitment from blood vessels to tissues have not been fully elucidated. We and others have reported that NK cells are rapid mobile cells during in vitro chemotaxis express adhesion molecules, which can recognize ligands on resting and inf l a m e d endothelium",'z or extracellular matrix protein^,'^.'^ and are able to actively transmigrate across endothelial monolayer^.'^ These functions are modulated by cytokines. Interleukin-2 (IL-2), interferon (IFN)-y and tumor necrosis factor (TNF)-a stimulate their in vitro locomotor ability, and recently it was reported that E-8 is chemokinetic for IL-2-activated adherent NK cells.16"8 The adhesive interaction of NK cells to in vitro-cultured endothelial cells (EC) is upregulated by IL-2,I2,I9 while IL-4 partly inhibited their binding."
In the present work, we studied IL-12, a cytokine produced by B lymphocytes and monocytes in response to lipopolysaccharide (LPS) and bacterial products, recently cloned and IL-12 has important functions in the regulation and amplification of the immune response and inflammation." IL-12 regulates the cytotoxic activity, proliferation, and cytokine production of NK and T cell^^'^*^^'^ but no information is available on modulation of cell adherence or chemotaxis.
Our results show that IL-12 is chemotactic for NK cells and increases their in vitro binding to and killing of EC. Further, IL-12 induced directional migration of CD3-activated T lymphocytes and polymorphonuclear cells (PMN), but not resting T cells or monocytes.
MATERIALS AND METHODS
Culture media and reagents. The following reagents were used for separation of effector cells, cell culture, and experimental assays: pyrogen-free saline for clinical use and distilled water (Bieffe, Sondrio, Italy); medium RPM1 1640 (lox concentrated; Biochrom KG, Berlin, Germany); medium 199 (GIBCO, Paisley, UK); glutamine (GIBCO); penicillin and streptomycin (GIBCO); and aseptically collected fetal calf serum (FCS; Hyclone, Logan, UT). The routinely used tissue culture medium was RPM1 1640 with 2 mmol/L glutamine, 50 mg/mL gentamicin, and 10% FCS, which is hereafter referred to as complete medium.
All reagents were checked for endotoxin contamination by the Limulus amebocyte lysate assay (Microbiological Associates. Walkersville, MD) with a sensitivity of 0.02 to 0.05 nglmL Escherichia coli Westphal LPSs. Sera were tested after 1:3 dilution and heating at 100°C. All reagents were negative for endotoxin contamination.
Preparation of leukocyte populations. Leukocytes were obtained from buffy coats of blood donors from normal volunteers through the courtesy of Centro Transfusionale, Ospedale Sacco, Milan, Italy, by centrifugation on Ficoll-Hypaque gradient. PMN were isolated as de~cribed.'~ Briefly, cells from the pellet of the Ficoll-Hypaque gradient (Biochrom KG, Berlin, Germany) were resuspended in isoosmotic (285 mOsm) complete medium, layered onto 62% isoosmotic Percoll gradient (diluted with complete medium), and spun at 450g for 20 minutes. Cells were collected at the mediudPercoll interface. The purity of PMN preparations was more than 95%, as assessed morphologically on Giemsa-stained cytopreps. Monocytes were separated on 46% Percoll gradients as described.** Preparations were usually more than 85% pure as assessed by positivity with monoclonal antibody (MoAb) anti-CD14.
Highly enriched NK-cell populations were prepared by discontinuous (478, 49%, and 52%) Percoll gradients as previously de~c r i b e d .~ Low-density cells were further depleted of contaminating T lymphocytes by panning with MoAb anti-CD6 (50 ng/mL)." Cells from NK-enriched fractions were added to the dishes and incubated at 4°C for I hour. The nonadherent cells were then gently poured off. The resulting NK populations were less than 3% CD3+ and more than 80% CD16+ and CD56'.
T lymphocytes were obtained from the high-density fractions of discontinuous Percoll gradients and further purified by positive panning on CD6-coated petri dishes. In some experiments, T cells were separated in CD4 and CD8 subsets by panning. For activation with anti-CD3, T cells were treated with a saturating amount of anti-CD3 MoAb and incubated on a plastic Petri dish previously coated with affinity-purified goat-antimouse IgG (1 0 pg/mL; Sigma Chemical CO, St Louis, MO) for 1 hour at 4°C. Nonadherent cells were gently poured off and cell incubation was continued at 37°C for an additional 4 hours.
Migration assay. Cell migration was evaluated using a microchamber technique" as previously described for monocytes and PMN?' and for NK cells and T cells.7 Twenty-five 2 1 pL chemoattractant diluted in RPM1 with 1% FCS was seeded in the lower compartment of the chemotaxis chamber and 50 pL cell suspension (I .5 X IOh/mL monocytes in peripheral blood mononuclear cells (PBMC) or PMN or 2 X 106/mL LGL or T lymphocytes) were seeded in the upper compartment. The two compartments were separated by 8-pm pore size nitrocellulose or polyvinylpyrrolidone-free polycarbonate membranes (Nucleopore Corp, Pleasanton, CA). Chambers were incubated at 37°C in air with 5% COz for I .5 hours (monocytes), 2 hours (PMN), 4 hours (LGL), or 3 hours (T cells). At the end of the incubation, nitrocellulose filters were removed, tixed, stained, and dehydrated using standard histologic methods. Five fields were examined for each sample. Migration was expressed as the distance (in microns) migrated by the two leading cells. Expected values of migration, assuming no chemotactic response, were calculated as described by Zigmond and Hirsch.'" Polycarbonate filters were fixed and stained with Diff-Quik (Baxter, Diidinzen, Germany) and five high-power oil fields were counted. Migration was expressed as the number of cells migrated across the filter.
Preparation of EC. Human EC were obtained from umbilical vein and cultured as previously described." Routinely, we used confluent cells (105/2 cmz culture well) between the first and fourth passage maintained in 199 medium with 20% bovine serum (Hyclone), supplemented with EC growth supplement (50 pg/mL; Collaborative Research Inc, Lexington, MA) and heparin (100 pg/ mL; Sigma). The purity of EC cultures was checked by expression of von Willebrand factor and found to be more than 99% positive.
Anfibodies MoAbs were used at a previously determined optimal concentration," usually 11100 for ascites or diluted 115 to 10 for hybridoma supernatants. NK cells were pretreated for 15 minutes at room ten]-perature with MoAbs and then plated (without washing out the MoAb) in the adhesion assay. In each experiment. isotype-matched antibodies were used as negative control. Adhesion a.s.say. Adhesion of NK cells to EC was studied as described previously.'' EC were grown to confluence in flat-bottomed 96-well trays and, in some experiments, were activated for 20 hours with 10 ng/mL of L I P ( D o m e , L'Aquila Italy).
NK-cell preparations were resuspended at 2 X IO%L in complete medium and incubated overnight with the stimulating cytokine. Control NK cells were incubated in medium alone. At the end of the culture period, cells were washed with saline and resuspended in complete medium at 10'/mL for labeling with 1 0 0 p,Ci "Cr (sodium chromate; Amersham, Bucks, UK) at 37°C for I hour. Cells were then washed with medium and resuspended at IOh/mL, 0. I mL was dispensed to each 96-well tray and incubated for 30 minutes at 37°C. At the end of the incubation, the wells were carefully washed three times with phosphate-buffered saline (PBS) plus 1% fetal bovine serum; adherent cells were solubilized with 0.2 mL of 0.025 mollL NaOH and 0.1% sodium dodecyl sulfate (SDS), and radioactivity was counted in a gamma counter, Results are presented as the percentage of adherent cells ? SD, with 3 to 6 replicates per group. Statistical analysis was performed by the Mann-Whitney test.
Cyrotoxiciry assay. The cytotoxic assay was performed as described." EC were labeled with 50 pL 5'Cr (Amersham) for l hour, and 5 x IO' EC were cocultured with a different concentration of NK cells previously treated with IL-2 or TL-12 for 24 hours. After a 4-hour incubation, supernatants were harvested and counted in a gamma counter for determination of isotope release. Results are presented as percent specific lysis (mean 2 SD) of three replicates per group. In the first series of experiments, we tested the chemotactic activity of IL-12 on purified NK cells and for comparison on other leukocyte populations. Figure 1 A shows a representative dosetresponse experiment. A chemotactic effect was observed in a narrow dose range, with a peak at 7.5 ngtmL of IL-12; the curve was typically bell-shaped, as for many chemoattractants. At the optimal concentration of 7.5 ng/mL, IL-12 was as active as an optimal concentration (50 ng/mL) of recombinant C5a. This result was confirmed in eight experiments with different blood donors. When an MoAb anti-IL-1 2 or boiled IL-12 were added in the assay, no migration occurred, confirming the specificity of the response (Fig le) . This enhanced locomotor activity of NK cells was chemotactic rather than chemokinetic, as demonstrated in checkerboard experiments, although a chemotactic component was also present (Table  1 ). Purified populations of T lymphocytes (>98% CD3+) responded to IL-12 only when appropriately stimulated with anti-CD3 MoAb. Resting T cells (Fig 2A) or T cells incubated with an irrelevant MoAb (data not shown) did not respond. IL-12 was as potent as recombinant C5a in inducing T-cell migration. We also investigated whether the CD4 and CD8 subset differed in their chemotactic response to IL-12. Purified preparations of CD4' and CD8' T cells, preactivated with MoAb anti-CD3, showed similar chemotactic activity (Fig 2B) .
RESULTS

Chemotactic activity
While monocytes did not show increased locomotor activity in response to IL-12 (data not shown), surprisingly, purified preparations of PMN showed a significant and reproducible chemotactic response to IL-12, with a peak effect at 5 ng/mL. Figure 3A shows a typical experiment representative of seven performed, IL-12 activity on PMN was blocked by anti-IL-l2 MoAb, and the heat-treated cytokine was ineffective ( Fig 3B) . A checkerboard analysis was also performed for PMN, and it was found that IL-12 is chemotactic, although a small chemokinetic effect was also evident (data not shown).
IL-12 stimulates adhesion and cytotoxicity of NK cells to vascular endothelium. The effect of IL-l2 was also studied on the ability of NK cells to adhere in vitro to monolayers of cultured human EC. IL-12 increased NK-cell binding to resting, as well as to IL-1 -activated EC, as shown in the representative experiment in Fig 4, although IL-2, used in parallel as an NK-cell-activating cytokine, was a stronger stimulus compared with IL-12. This IL-12-increased binding was better observed when resting rather than activated EC were used as substratum for adhesion. In a large series of experiments, the estimated increase in NK-cell binding induced by IL-12 was 68% 2 10% and 33% 2 3% on resting and IL-l-activated EC, respectively (mean +-SE of 15 exper-iments, P < .OS).
As shown in Fig 5, a small increase in NK-cell binding to EC was already observed with 5 nglmL IL-12, and the peak effect was at 10 ng/mL. These concentrations were alsc the most effective in parallel experiments of tumor cytotoxicity against the K562 cell line (Fig 5) . The effect of IL-12 required an incubation time of more than 6 hours, and war optimal after an Overnight incubation (not shown). No increase in NK-cell binding was observed when EC were stimulated for 24 hours with IL-12 (data not shown).
As IL-12-induced stimulation of binding to EC requirec a relatively long exposure, we questioned whether a putative factor secreted by NK cells was, in fact, responsible for thc increased binding. IL-12 induces the production of severa' cytokines by NK cells, eg, IFNy and TNFmZ5 These cyto. kines have stimulating effects on NK-cell function, but dc not increase their binding ability to EC.*" Moreover, MoAbr against TNFa and IFNy did not decrease NK-cell binding (data not shown). Also, the supernatant of NK cells culturec overnight with IL-12 did not stimulate NK-cell binding (no shown). These experiments suggested that IL-12 acts directl) on the adhesive capacity of NK cells.
IL-2-activated NK cells are able to kill EC.zo.32.33 There. 
-rC5a
The observation that the greatest effect of IL-12 was seen CD18, caused us to check if this augmented functional activity was associated with an augmented expression of integrins.
."" " " " compared with anti-CD18 alone (Fig 7) . In several experiments, we were unable to demonstrate a ' i5 5 -consistent increased expression of p 2 integrins after incuba- fore, we investigated whether the increased binding of IL-12-activated NK cells to EC also resulted in increased cytotoxicity. As shown in Fig 6, unstimulated peripheral blood lymphocytes (PBL) did not lyse EC; after overnight exposure to XL-12, a significant increase of lysis was detected, although lower than that obtained after IL-2 stimulation.
Characterization of the adhesive molecules. In previous reports, we characterized the adhesive molecules involved in NK-cell binding to EC.'* Most binding of resting and IL-12-activated NK cells on resting EC was inhibited by antiCDlldCD18 MoAb, whereas MoAb anti-CDllb and C D l l c had no effect (Fig 7) . When EC were preactivated with IL-l, a clear role for the VLA-4NCAM-1 pathway was In parallel experiments, it was found that CD3-activated T cells and PMN responded to a gradient of IL-12. The locomotor ability of T lymphocytes has recently received much attention after the reports that some members of the newly described chemokine family are active on T Macrophage inflammatory protein la (MIPla) was reported to preferentially chemoattract CD3-activated CD8+ T cells, while MIPlp preferentially attracted CD4' T cells. RANTES was active on unstimulated CD4+CD45RO+ memory T cells and stimulated CD4+ and CD8' lymphocytes. Finally, interferon-inducible protein 10 chemoattracted both stimulated CD4' and CD8' lymphocytes. In this study, IL-12 induced a chemotactic response only in CD3-activated, CD4+, and CD8' lymphocytes, indicating that the state of cell activation might be crucial for their recruitment in vivo.
IL-12 was also chemotactic for PMN and chemotactic activity was abrogated by anti-IL-12 MoAb and by boiling the cytokine, thus excluding a nonspecific effect. Furthermore, the supernatant from mononuclear cells or purified PMN cultured for 2 hours with IL-12 (the length of the chemotaxis assay) was not active in inducing directional migration of freshly isolated PMN, suggesting that IL-12 is working directly, and not by inducing the secretion of a second factor (data not shown). We failed to observe modulation of other functions of PMN by IL-12, including expression of mRNA levels for IL-6, IL-lp, L-l receptor antagonist (IRA), L-l receptor type I and type 11, cyos, c-Jun, and cmyc. The significance of this selective effect of L 1 2 on mature myelocytes (monocytes were unaffected) remains to be defined.
We and others have reported that NK cells bind to EC and that this interaction is modulated by cytokines."." It was, therefore, of interest to study the action of IL-12 at this level. IL-12 augmented the number of NK cells that bound to resting EC (68%) and activated EC (33%). This effect of IL-12 showed several differences compared with the effect induced by IL-2, a prototypic NK-cell-stimulating cytokine: (1) IL-2 had a more marked effect compared with IL-12; ( 2 ) the kinetics of L 1 2 were slower, as it required overnight treatment, while a l-hour exposure to IL-2 was sufficient to give a aignificant increase in NK-cell binding"; and (3) IL-"-augmented binding was inhibited by IL-4,"' while the latter cytokme does not inhibit the effect of IL-12 (data not shown). IL-4 was also ineffective in inhibiting the IL-12-augmented NK-cell cytotoxicity." It is of interest that 1L-4-treated monocytes showed a decreased secretion of IL-12."l One of the mechanisms through which [L-12 might mediate effects on NK cells invoives the adhesion molecules critical for the interaction between NK and EC. Robertson et aliy have reported that IL-12 augments some adhesion molecules on NK cells, including CD1 la, CD54, and CD%, and this could explain the increased cytotoxicity. Also, Rabinovich et all' have recently reported augmented expression of 0 2 mtegrin on IL-12-activated NK cells." However, this increased expression was observed after a relatively long incubation with L 1 2 (6 days' culture), while we detected NK-cell augmentation of tumor killing and EC binding as early as 24 hours after incubation. Moreover, the effect on chemotaxis was readily observed in a 2-hour assay. In this study, we tested the expression of 0 2 integrins by fluorescence-activated cell sorter (FACS) with the ~nost widely used anti-CD1 I $CD1 8 MoAb, and did not find a consistent modification of expression, despite increased binding to EC. However, we did find an increased expression of an activation epitope of LFA-1 recognized by MoAb NKI-L 16." Rabinovich et ai4' have reported that IL-12 did not induce NK-cell binding to fibronectin and iaminin-coated plastic. Moreover, 0401 integrin expression was not augmented after h days' incubation with IL-12." These results further support that the IL-12-activated NK-cell binding to EC is not mediated by modulation of a401 integrin. Thus, some evidences concur with the conclusion that IL-12 augments the adhesive abllity of N K cells by affecting the LFA-i molecule. This effect is most likely due to activation of the molecule, rather than augmented expression. 
